Alnylam Pharmaceuticals
ALNY
#449
Rank
โ‚น4.695 T
Marketcap
โ‚น35,541
Share price
-2.47%
Change (1 day)
72.71%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company